A prospective randomized trial examining health care utilization in individuals using multiple smartphone-enabled biosensors

PeerJ

Volumn 2016, Issue 1, 2016, Pages

  Bloss, Cinnamon S ^a   Wineinger, Nathan E ^a   Peters, Melissa ^a   Boeldt, Debra L ^a   Ariniello, Lauren ^a   Kim, Ju Young ^b   Sheard, Judith ^a   Komatireddy, Ravi ^a   Barrett, Paddy ^a   Topol, Eric J ^a,c,d  

^a SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^b Seoul National University Bundang Hospital   (South Korea)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d SCRIPPS HEALTH   (United States)

Author keywords

Arrhythmia; Diabetes; Digital medicine; Health insurance claims; Health monitoring; Hypertension; Mobile health

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOSENSOR; COMMUNITY CARE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; ENGINEERING AND TECHNOLOGY; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; SMARTPHONE;

EID: 84961751204     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.1554     Document Type: Article

References (26)

1. American Diabetes Association. 2014. National Diabetes Statistics Report, 2014 estimates of diabetes and its burden in the epidemiologic estimation methods. National Diabetes Statistics Report (4):2009-2012 DOI 10.2196/jmir.4456.
2. Boeldt DL, Wineinger NE, Waalen J, Gollamudi S, Grossberg A, Steinhubl SR, McCollister-Slipp A, Rogers MA, Silvers C, Topol EJ. 2015. How consumers and physicians view new medical technology: comparative survey. Journal of medical Internet research 17(4):e215 DOI 10.2196/jmir.4456.
3. Chobanian AV, Bakris GL, Black HR, CushmanWC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. 2003. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6):1206-1252 DOI 10.1161/01.HYP.0000107251.49515.c2.
4. Davis KE. 2013. Expenditures for hypertension among adults age 18 and older, 2010: estimates for the U.S. Civilian Noninstitutionalized Population April 2013. Available at http://meps.ahrq.gov/mepsweb/data_files/publications/st404/stat404.shtml.
5. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman MB, Bergus GR. 2006. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47(3):352-358 DOI 10.1161/01.HYP.0000203309.07140.d3.
6. Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, Patel V, Haines A. 2013a. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Medicine 10:e1001362 DOI 10.1371/journal.pmed.1001362.
7. Free C, Phillips G, Watson L, Galli L, Felix L, Edwards P, Patel V, Haines A. 2013b. The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS medicine 10:e1001363 DOI 10.1371/journal.pmed.1001363.
8. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. 1986. Determining optimal therapy-randomized trials in individual patients. New England Journal of Medicine 314(14):889-892 DOI 10.1056/NEJM198604033141406.
9. Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. 2015. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. Journal of Medical Internet Research 17(2):e52 DOI 10.2196/jmir.3951.
10. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. 2005. Ambulatory blood pressure and mortality: a population-based study. Hypertension 45(4):499-504 DOI 10.1161/01.HYP.0000160402.39597.3b.
11. Hibbard JH, Mahoney ER, Stockard J, Tusler M. 2005. Development and testing of a short form of the patient activation measure. Health Services Research 40(6):1918-1930 DOI 10.1111/j.1475-6773.2005.00438.x.
12. Karhula T, Vuorinen A-L, Rääpysjärvi K, Pakanen M, Itkonen P, Tepponen M, Junno U-M, Jokinen T, van Gils M, Lähteenmäki J, Kohtamäki K, Saranummi N. 2015. Telemonitoring and mobile phone-based health coaching among finnish diabetic and heart disease patients: randomized controlled trial. Journal of Medical Internet Research 17(6):e153 DOI 10.2196/jmir.4059.
13. Kim MH, Johnston SS, Chu B-C, Dalal MR, Schulman KL. 2011. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circulation: Cardiovascular Quality and Outcomes 4(3):313-320 DOI 10.1161/CIRCOUTCOMES.110.958165.
14. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. 1989. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis and Rheumatism 32(1):37-44 DOI 10.1002/anr.1780320107.
15. National Institute for Health Care Excellence 2015. London: Department of Health. Available at https://www.nice.org.uk/(accessed October 12, 2015).
16. Sander GE, Giles TD. 2011. Resistant hypertension: concepts and approach to management. Current Hypertension Reports 13(5):347-355 DOI 10.1007/s11906-011-0226-7.
17. Steinhubl SR, Muse ED, Topol EJ. 2013. Can mobile health technologies transform health care? The Journal of the American Medical Association 310(22):2395-2396 DOI 10.1001/jama.2013.281078.
18. Steinhubl SR, Muse ED, Topol EJ. 2015. The emerging field of mobile health. Science translational medicine 7(283):1-6 DOI 10.1126/scitranslmed.aaa3487.
19. The ALLHAT Officers. 2002. Major outcomes in high-risk hypertensive patients randomized to or calcium channel blocker vs diuretic. Journal of the American Medical Association 288(15):2981-2997 DOI 10.1001/jama.283.15.1967.
20. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. 2000. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Journal of the American Medical Association 283:1967-1975.
21. Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G. 2005. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin a nephropathy treated with angiotensin II modulators. Journal of Hypertension 23(4):861-865.
22. Wallston KA, Stein MJ, Smith CA. 1994. Form C of the MHLC scales: a condition-specific measure of locus of control. Journal of Personality Assessment 63(3):534-553 DOI 10.1207/s15327752jpa6303_10.
23. Willits I, Keltie K, Craig J, Sims A. 2014. WatchBP home a for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: a NICE medical technology guidance. Applied Health Economics and Health Policy 12(3):255-265 DOI 10.1007/s40258-014-0096-7.
24. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. 1998. Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847 DOI 10.1161/01.CIR.97.18.1837.
25. Yang W, Dall TM, Halder P, Gallo P, Kowal SL, Hogan PF, Petersen M. 2013. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36(4):1033-1046 DOI 10.2337/dc12-2625.
26. Zhang B, Kumar RB, Dai H, Feldman BJ. 2014. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Nature Medicine 20:948-953 DOI 10.1038/nm.3619.